MANDARIN

S6371 · Boston Scientific Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MANDARIN, covering 2026-08-12 to 2026-08-12. Get the full timeline:

Most recent: Clinical Trial Update: MANDARIN (S6371) [Phase 3]